Dergiler / BEYOGLU EYE JOURNAL / 2021 / Cilt: 6 - Sayı: 1

Maculopathy, Fundus Changes and Anterior Lenticonus in Alport Syndrome

Sayfa
66–69
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The patient's close relatives should also be examined.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Alport syndrome is a rare basement membrane disorder that may include ocular manifestations: dot-and-fleck retinopathy, anterior lenticonus, posterior polymorphous corneal dystrophy, or temporal macular thinning.
📊
Temel Bulgular & Veri:It is primarily anX-linked inheritance condition (85%).
💡
Sonuç & Katkı:The patient's close relatives should also be examined.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Alport syndrome is a rare basement membrane disorder that may include ocular manifestations: dot-and-fleck retinopathy, anterior lenticonus, posterior polymorphous corneal dystrophy, or temporal macular thinning. It is primarily anX-linked inheritance condition (85%). This case report describes a 51-year-old male patient with Alport syndrome who was diagnosed due to ocular manifestations that were subsequently linked with a history of renal failure and bilateral sensorineural hearing loss. The diagnostic tools used were biomicroscopy, ultrasound, corneal topography, endothelial microscope analysis, macula optical coherence tomography, and fundus photography. Clear lens extraction was performed and improved his visual acuity. Further genetic analysis revealed a mutation in the COL4A5 gene on the X chromosome. Ocular manifestations can help determine the right diagnosis and help in multisystemic disease assessment. In cases of Alport syndrome, a nephrologist should be informed about the potential development of a specific antiglomerular basement membrane antibody that may lead to graft rejection. The patient's close relatives should also be examined.

🔖

Bu Makaleye Atıf Yap

RATKOVİC, M., PİDRO, A., PİDRO, A. (2021). Maculopathy, Fundus Changes and Anterior Lenticonus in Alport Syndrome. BEYOGLU EYE JOURNAL, Cilt: 6 - Sayı: 1, 66–69. https://ajindex.com/articles/353103

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Savige J., Sheth S., Leys A. Ocular features in Alport’s syndrome: pathogenesis and clinical significance. Clin J Am Soc Nephrol 2015;10:703–9
  2. Temme J, Kramer A, Jager KJ, Lange K, Peters F, Müller GA, et al. Outcomes of male patients with Alport syndrome undergoing renal replacement therapy. Clin J Am Soc Nephrol 2012;7:1969–76
  3. Raja AM, Janti SS, Matheen A, Chendilnathan C. Ocular manifestation of the Alport syndrome: A case report. Muller J Med Sci Res 2015;6:89–91
  4. Kabosova A, Azar DT, Bannikov GA, Campbell KP, Durbeej M, Ghohestani RF, et al. Compositional differences between infant and adult human corneal basement membranes. Invest Ophthalmol Vis Sci 2007;48:4989–99
  5. Xu JM, Zhang SS, Zhang Q, Zhou YM, Zhu CH, Ge J, Wang L. Ocular manifestations of Alport syndrome. Int J Ophthalmol 2010;3:149–51
  6. Kashtam CE, Michael AF. Alport syndrome: from bedside to genome to bedside. Am J Kidney Dis 1993;22:627–40. [CrossRef ] 7. Rhys C, Snyers B, Pirson Y: Recurrent corneal erosion associated with Alport’s syndrome. Rapid communication. Kidney Int 1997;52:208–11
  7. Burke JP, Clearkin LG, Talbot JF. Recurrent corneal epithelial erosions in Alport’s syndrome. Acta Ophthalmol (Copenh) 1991;69:555–7
  8. Ohkubo S, Takeda H, Higashide T, Ito M. Immunohistochemical and molecular genetic evidence for type IV collagen alpha5 chain abnormality in the anterior lenticonus associated with Alport syndrome. Arch Ophthalmol 2003;121:846–50
  9. Liu YB, Tan SJ, Sun ZY, Li X, Huang BY, Hu QM. Clear lens phacoemulsification with continuous curvilinear capsulorhexis and foldable intraocular lens implantation for the treatment of a patient with bilateral anterior lenticonus due to Alport syndrome. J Int Med Res 2008;36:1440–4
  10. Ahmed F, Kamae KK, Jones DJ, Deangelis MM, Hageman GS, Gregory MC, Bernstein PS. Temporal macular thinning associated with X-linked Alport syndrome. JAMA Ophthalmol 2013;131:777–82
  11. Rahman W, Banerjee S. Giant macular hole in Alport syndrome. Can J Ophthalmol. 2007;42:314–5.